Interestingly, FYN, LRSAM1, IL20RB, CXCL11, S100A1, and MAP3K14 are also well-recognized biomarkers in the prognosis of renal cancer, which is reminiscent of the pancreatic metastasis from renal cell carcinoma in some earlier studies [48,49,50]. This evidence concerns the gene S100A1 and renal carcinoma.